"HCG NCHRI Cancer Centre, Nagpur, is the first private comprehensive cancer care hospital in Central India. HCG NCHRI Cancer Centre was founded with the aim of providing consistently high quality and result oriented cancer care treatment, by adopting global innovations."

During the past decade, HCG NCHRI Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "HCG NCHRI Cancer Center" are "Adenocarcinoma" (1 trials), "Breast Cancer" (1 trials), "Early Breast Cancer" (1 trials), "Fallopian Tube Neoplasms" (1 trials) and "Gastrointestinal Neoplasms" (1 trials). Many other conditions were trialed in "HCG NCHRI Cancer Center" in a lesser frequency.

Most popular intervention types in "HCG NCHRI Cancer Center" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Cisplatin and either Fluorouracil (5-FU) or Capecitabine or Oxaliplatin and capecitabine." (1 trials), "EG12014" (1 trials), "Endocrine Therapy of Physician's Choice" (1 trials) and "Giredestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "HCG NCHRI Cancer Center" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "HCG NCHRI Cancer Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in HCG NCHRI Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HCG NCHRI Cancer Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".